In medical device regulation, a remote audit follows the same objectives as an on-site visit: verify that the quality management system is implemented and effective. The difference is the medium. Notified bodies conducting ISO 13485 surveillance audits and regulatory authorities reviewing MDSAP submissions increasingly accept remote sessions for documentation-based activities, and several have formalised this in their audit programmes.
The practical difference matters. Remote audits handle document review, procedure walkthroughs, process interviews, and record examination efficiently. They do not replace physical inspection of manufacturing areas, equipment calibration records tied to physical assets, or product samples where tactile or visual assessment is part of the audit scope. When a site visit is required, a remote session can cover the documentation portion and leave the physical inspection for a shorter on-site segment.
Preparation determines how a remote audit goes. Auditors expect pre-shared document packs, stable remote access to the controlled document system, and a person who can navigate the QMS in real time. Open CAPAs, recent change requests, training matrices, risk files, and any outstanding corrective actions from the previous audit cycle are typically reviewed early. An organisation that can present these on demand, without hunting through folders or chasing colleagues, typically moves through a remote audit faster than one relying on paper binders.
FDA QSIT guidance and MDSAP protocols allow remote review of most documentation activities within surveillance and reassessment audits.
The whitepaper below shows how qmsWrapper supports remote audit preparation.
